Reference

FAQ

Discrete, individually linkable question-and-answer entries addressing recurring reader questions about interpreting clinical-AI evidence and regulatory status, such as whether FDA clearance equals clinical validation, what a given AUROC value means, or how the tracker defines an incident. Structured as standalone Q&A rather than narrative articles so each answer is directly citable and linkable. Every answer carries the standard informational disclaimer and links to the relevant glossary term, appraisal, or tracker methodology note; excludes open-ended discussion or opinion content.